ArticleCJC open2022

Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada.

Theresa E Eberhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.